Ronald B. Garren
Geen lopende functies
Profiel
Ronald B.
Garren is the founder who has founded Rigel Pharmaceuticals, Inc. in 1996, Kinexis, Inc. in 2002, and The Vaccine Co. in 2003.
At Kinexis, Inc. and The Vaccine Co., he held the title of Chairman from 2002 to 2011.
Dr. Garren's former jobs include being the President of AmpliMed Corp., a Research Consultant at Axion Capital Management LLC, and a Technology Consultant at Smolen Capital Management.
Dr. Garren received his undergraduate degree from Dartmouth College and his doctorate from Harvard Medical School.
Eerdere bekende functies van Ronald B. Garren
| Bedrijven | Functie | Einde |
|---|---|---|
Axion Capital Management LLC
 Axion Capital Management LLC Investment ManagersFinance Founded in 2001, Axion Capital Management LLC, formerly BioTech Insight Management LLC, is a hedge fund manager located in San Rafael, California. The firm's clients include global institutions, family offices and high net-worth individuals. They manage the Axion Opportunity Fund LP. | Analyst-Equity | 31-10-2010 |
| RIGEL PHARMACEUTICALS, INC. | Oprichter | - |
Smolen Capital Management
 Smolen Capital Management Investment ManagersFinance Founded by Joel Smolen in 1999, Smolen Capital Management is a registered investment advisor located in Pebble Beach, California. The firm offers asset management, long-term financial planning and specialized portfolio management as well as the Biotech Select Focus Portfolio | Analyst-Equity | - |
The Vaccine Co.
 The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Oprichter | - |
Kinexis, Inc.
 Kinexis, Inc. BiotechnologyHealth Technology Kinexis, Inc. developed technology that allows generation of antibody. The company was founded in 2002 by Ronald B. Garren and Patricia L. Kilian and is headquartered in San Diego, CA. | Oprichter | - |
Opleiding van Ronald B. Garren
| Dartmouth College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Axion Capital Management LLC
Axion Capital Management LLC Investment ManagersFinance Founded in 2001, Axion Capital Management LLC, formerly BioTech Insight Management LLC, is a hedge fund manager located in San Rafael, California. The firm's clients include global institutions, family offices and high net-worth individuals. They manage the Axion Opportunity Fund LP. | Finance |
AmpliMed Corp.
 AmpliMed Corp. Pharmaceuticals: MajorHealth Technology AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ. | Health Technology |
Kinexis, Inc.
Kinexis, Inc. BiotechnologyHealth Technology Kinexis, Inc. developed technology that allows generation of antibody. The company was founded in 2002 by Ronald B. Garren and Patricia L. Kilian and is headquartered in San Diego, CA. | Health Technology |
The Vaccine Co.
The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Smolen Capital Management
Smolen Capital Management Investment ManagersFinance Founded by Joel Smolen in 1999, Smolen Capital Management is a registered investment advisor located in Pebble Beach, California. The firm offers asset management, long-term financial planning and specialized portfolio management as well as the Biotech Select Focus Portfolio | Finance |
